Earlier Initiation of Antiretroviral Treatment Coincides With an Initial Control of the HIV-1 Sub-Subtype F1 Outbreak Among Men-Having-Sex-With-Men in Flanders, Belgium.

Belgium HIV-1 men-having-sex-with-men phylodynamics sub-subtype F1 treatment as prevention

Journal

Frontiers in microbiology
ISSN: 1664-302X
Titre abrégé: Front Microbiol
Pays: Switzerland
ID NLM: 101548977

Informations de publication

Date de publication:
2019
Historique:
received: 13 10 2018
accepted: 11 03 2019
entrez: 12 4 2019
pubmed: 12 4 2019
medline: 12 4 2019
Statut: epublish

Résumé

Human immunodeficiency virus type 1 (HIV-1) non-B subtype infections occurred in Belgium since the 1980s, mainly amongst migrants and heterosexuals, whereas subtype B predominated in men-having-sex-with-men (MSM). In the last decade, the diagnosis of F1 sub-subtype in particular has increased substantially, which prompted us to perform a detailed reconstruction of its epidemiological history. To this purpose, the Belgian AIDS Reference Laboratories collected HIV-1

Identifiants

DOI: 10.3389/fmicb.2019.00613 PMID: 30972053 PMC: PMC6443750
pubmed: 30972053
doi: 10.3389/fmicb.2019.00613
pmc: PMC6443750
doi:

Types de publication

Journal Article

Langues

eng

Pagination

613

Références

Virology. 1999 Jun 20;259(1):99-109
pubmed: 10364493
AIDS Res Hum Retroviruses. 2000 Mar 1;16(4):327-36
pubmed: 10716370
J Virol. 2000 Nov;74(22):10498-507
pubmed: 11044094
AIDS. 2003 May 2;17(7):1063-9
pubmed: 12700457
Nat Rev Genet. 2004 Jan;5(1):52-61
pubmed: 14708016
Nucleic Acids Res. 2004 Mar 19;32(5):1792-7
pubmed: 15034147
J Acquir Immune Defic Syndr. 2004 Mar 1;35(3):279-85
pubmed: 15076243
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):57-64
pubmed: 16123683
Infect Genet Evol. 2007 Mar;7(2):263-70
pubmed: 17150415
Infect Genet Evol. 2007 Jun;7(3):391-8
pubmed: 17360244
AIDS Res Hum Retroviruses. 2007 Oct;23(10):1176-82
pubmed: 17961101
AIDS Res Hum Retroviruses. 2008 Mar;24(3):355-62
pubmed: 18327983
Int J Infect Dis. 2009 Jan;13(1):81-9
pubmed: 18632295
J Acquir Immune Defic Syndr. 2008 Dec 1;49(4):432-9
pubmed: 18931623
PLoS One. 2009;4(3):e4724
pubmed: 19266092
Retrovirology. 2009 Apr 22;6:39
pubmed: 19386115
Nucleic Acids Res. 2009 Jul;37(Web Server issue):W647-51
pubmed: 19443440
Retrovirology. 2009 May 20;6:49
pubmed: 19457244
J Antimicrob Chemother. 2009 Sep;64(3):607-15
pubmed: 19608581
PLoS One. 2010 Jul 09;5(7):e11505
pubmed: 20634893
BMC Infect Dis. 2010 Sep 07;10:262
pubmed: 20822507
AIDS. 2011 Mar 13;25(5):679-89
pubmed: 21297424
Infect Genet Evol. 2011 Jul;11(5):975-9
pubmed: 21439403
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
N Engl J Med. 2011 Aug 11;365(6):493-505
pubmed: 21767103
Syst Biol. 2012 Jan;61(1):170-3
pubmed: 21963610
AIDS Res Hum Retroviruses. 2012 Sep;28(9):1161-6
pubmed: 22251065
J Acquir Immune Defic Syndr. 2012 Mar 1;59(3):e49-51
pubmed: 22327248
Infect Genet Evol. 2012 Jul;12(5):1079-86
pubmed: 22484759
PLoS One. 2012;7(8):e42223
pubmed: 22876310
PLoS One. 2012;7(8):e42996
pubmed: 22952625
Proc Natl Acad Sci U S A. 2013 Jan 2;110(1):228-33
pubmed: 23248286
Retrovirology. 2013 Jan 14;10:7
pubmed: 23317093
PLoS One. 2013;8(3):e59666
pubmed: 23527245
Infect Genet Evol. 2013 Oct;19:337-48
pubmed: 23660484
Jpn J Infect Dis. 2013;66(4):306-11
pubmed: 23883841
J Med Virol. 2014 Feb;86(2):186-92
pubmed: 24122963
AIDS Rev. 2014 Jan-Mar;16(1):23-34
pubmed: 24584106
PLoS Comput Biol. 2014 Apr 10;10(4):e1003537
pubmed: 24722319
AIDS. 2014 Jul 31;28(12):1837-40
pubmed: 24871456
PLoS One. 2014 Jul 08;9(7):e101738
pubmed: 25003369
Nucleic Acids Res. 2014 Oct;42(18):e144
pubmed: 25120265
Science. 2014 Oct 3;346(6205):56-61
pubmed: 25278604
AIDS Res Hum Retroviruses. 2015 May;31(5):488-95
pubmed: 25369079
Infect Genet Evol. 2015 Mar;30:96-101
pubmed: 25527396
J Antimicrob Chemother. 2015;70(6):1874-80
pubmed: 25652746
J Clin Microbiol. 2015 May;53(5):1506-14
pubmed: 25694526
N Engl J Med. 2015 Aug 27;373(9):795-807
pubmed: 26192873
BMC Infect Dis. 2015 Nov 03;15:496
pubmed: 26530500
Nucleic Acids Res. 2016 Jul 8;44(W1):W242-5
pubmed: 27095192
Lancet Infect Dis. 2016 Jul;16(7):789-796
pubmed: 27174504
Virology. 2016 Aug;495:173-84
pubmed: 27228177
Infect Genet Evol. 2016 Dec;46:169-179
pubmed: 27262355
JAMA. 2016 Jul 12;316(2):171-81
pubmed: 27404185
Virus Evol. 2016 Apr 09;2(1):vew007
pubmed: 27774300
Nature. 2016 Nov 3;539(7627):98-101
pubmed: 27783600
J Virol. 2017 Feb 28;91(6):
pubmed: 28077647
AIDS. 2018 Jan 2;32(1):121-125
pubmed: 29112068
BMC Infect Dis. 2017 Nov 29;17(1):738
pubmed: 29187159
Syst Biol. 2018 Sep 1;67(5):901-904
pubmed: 29718447
Virus Evol. 2018 Jun 08;4(1):vey016
pubmed: 29942656
Lancet HIV. 2018 Aug;5(8):e438-e447
pubmed: 30025681
J Infect Dis. 1994 Feb;169(2):281-8
pubmed: 8106761
Lancet. 1996 May 18;347(9012):1403
pubmed: 8637352
Emerg Infect Dis. 1995 Jul-Sep;1(3):91-3
pubmed: 8903171
AIDS. 1998 Jun 18;12(9):1079-85
pubmed: 9662205
J Virol. 1999 Jan;73(1):152-60
pubmed: 9847317

Auteurs

Lore Vinken (L)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

Katrien Fransen (K)

AIDS Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Lize Cuypers (L)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

Ivailo Alexiev (I)

National Reference Confirmatory Laboratory of HIV, National Center of Infectious and Parasitic Diseases, Sofia, Bulgaria.

Claudia Balotta (C)

Infectious Diseases and Immunopathology Section, 'L. Sacco' Department of Biomedical and Clinical Sciences, 'L. Sacco' Hospital, University of Milan, Milan, Italy.

Laurent Debaisieux (L)

AIDS Reference Laboratory, CUB-Hopital Erasme, Université Libre de Bruxelles, Brussels, Belgium.

Carole Seguin-Devaux (C)

Laboratory of Retrovirology, Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg.

Sergio García Ribas (S)

AIDS Reference Laboratory, Department of Clinical Sciences, Institute of Tropical Medicine Antwerp, Antwerp, Belgium.

Perpétua Gomes (P)

Serviço de Patologia Clínica, Laboratorio de Biologia Molecular, LMCBM, Centro Hospitalar Lisboa Ocidental, Hospital Egas Moniz, Lisbon, Portugal.
Centro de Investigação Interdisciplinar Egas Moniz, Instituto Universitário Egas Moniz, Almada, Portugal.

Francesca Incardona (F)

EuResist Network GEIE, Rome, Italy.

Rolf Kaiser (R)

Institute of Virology, University of Cologne, Cologne, Germany.

Jean Ruelle (J)

Unit of Medical Microbiology, Institute of Experimental and Clinical Research, Université catholique de Louvain, Brussels, Belgium.

Murat Sayan (M)

PCR Unit, Clinical Laboratory, Kocaeli University, İzmit, Turkey.
Research Center of Experimental Health Sciences, Near East University, Nicosia, Cyprus.

Simona Paraschiv (S)

Molecular Diagnostics Laboratory, National Institute for Infectious Diseases 'Matei Bals', Bucharest, Romania.

Roger Paredes (R)

IrsiCaixa AIDS Research Institute, Universitat Autònoma de Barcelona, Badalona, Spain.

Martine Peeters (M)

UMI 233 TransVIHMI/INSERM1175, Institut de Recherche pour le Développement, University of Montpellier, Montpellier, France.

Anders Sönnerborg (A)

Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institutet, Stockholm, Sweden.

Ellen Vancutsem (E)

AIDS Reference Laboratory, Department of Microbiology and Infection Control, Universitair Ziekenhuis Brussel, Brussels, Belgium.

Anne-Mieke Vandamme (AM)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Unidade de Microbiologia, Center for Global Health and Tropical Medicine, Instituto de Higiene e Medicina Tropical, Universidade Nova de Lisboa, Lisbon, Portugal.

Sigi Van den Wijngaert (S)

AIDS Reference Laboratory, Department of Microbiology, Saint-Pierre University Hospital, Brussels, Belgium.

Marc Van Ranst (M)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
AIDS Reference Laboratory, University Hospitals Leuven, Leuven, Belgium.

Chris Verhofstede (C)

AIDS Reference Laboratory, Department of Clinical Chemistry, Microbiology and Immunology, Ghent University, Ghent, Belgium.

Tanja Stadler (T)

Department of Biosystems Science and Engineering, ETH Zürich, Basel, Switzerland.
Swiss Institute of Bioinformatics, Lausanne, Switzerland.

Philippe Lemey (P)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.

Kristel Van Laethem (K)

Laboratory of Clinical and Epidemiological Virology, Department of Microbiology and Immunology, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
AIDS Reference Laboratory, University Hospitals Leuven, Leuven, Belgium.

Classifications MeSH